Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients
RecruitingOBSERVATIONAL
Enrollment
159
Participants
Timeline
Start Date
August 29, 2025
Primary Completion Date
August 31, 2028
Study Completion Date
August 31, 2028
Conditions
Multiple Myeloma
Trial Locations (1)
Unknown
RECRUITING
Aou Careggi - Sod Ematologia, Florence
All Listed Sponsors
lead
Gruppo Italiano Malattie EMatologiche dell'Adulto
OTHER
NCT06933277 - Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients | Biotech Hunter | Biotech Hunter